Escitalopram-Induced Chronic Euvolemic Hyponatremia
Jayalakshmi K. Prakash1, M. T. Abhirami1, Navya Sri G1, Varsha I. Dalal1★, AHMV Swamy1, Kurian Thomas1★ Corresponding author
- 1Department of Pharmacy Practice, KLE College of Pharmacy, Hubballi, Karnataka, India.
CORRESPONDENCE
Varsha I. Dalal
Department of Pharmacy Practice, KLE College of Pharmacy, Vidya Nagar, Hubballi, Karnataka, India.
Received: 04-08-2021; Revised: 29-08-2021; Accepted: 20-10-2021.
Volume 12, Issue 4 · pp. 180–182 · PUBLISHED 9 February 2022 · DOI: 10.4103/jpp.jpp_102_21
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Selective serotonin reuptake inhibitors (SSRIs), through the recent years have seen an increase in the number of prescriptions for a spectrum of mood disorders, especially in the geriatric population. Despite being a well-tolerated antidepressant, SSRIs have been associated with hyponatremia, a rare, but fatal adverse effect and the incidence ranges from 0.5%–32% in literature. Euvolemic hyponatremia is most commonly associated with syndrome of inappropriate secretion of antidiuretic hormone. An extensive review of literature was carried out, and we came across a total of 20 cases where escitalopram was reported as the causative agent of hyponatremia. We report a case of an 82-year-old female patient who had a history of acute onset, progressive memory impairment, and behavioral changes with depressive cognition precipitated by the death of her husband, for which she was treated with escitalopram 5 mg/day and clonazepam 0.5 mg/day. She was admitted to the hospital with presenting complaints of gait imbalance, tremors, irritability, confusion, decreased speech output and persecutory delusions. She was diagnosed with late-onset organic psychosis, precipitated and worsened by escitalopram-induced chronic uncontrolled euvolemic hyponatremia, with a sodium level of 115 mmol/L. On discontinuation of escitalopram, the patient’s serum sodium level improved gradually, and her consciousness became better. This is the second case with recurrent hyponatremia in the literature up to this date, with the other being reported by Tsai et al., in 2012. Furthermore, the dose of escitalopram was only 5 mg/day compared to other reported cases where the dose ranged between 10–20 mg/day.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Prakash, J. K., Abhirami, M. T., G, N. S., Dalal, V. I., Swamy, A., & Thomas, K. (2022). Escitalopram-Induced Chronic Euvolemic Hyponatremia. Journal of Pharmacology and Pharmacotherapeutics, 12(4), 180–182. https://doi.org/10.4103/jpp.jpp_102_21
